Group One Trading
ACRS icon

Group One Trading’s Aclaris Therapeutics ACRS Stock Holding History

Group One Trading’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.13K Buy
+1,100
New +$3.71K ﹤0.01% 6789
2025
Q2 		– Sell
-200
Closed -$306 – 7856
2025
Q1 		$306 Buy
+200
New +$427 ﹤0.01% 7341
2024
Q3 		– Sell
-300
Closed -$330 – 6555
2024
Q2 		$330 Sell
300
-43,900
-99% -$51.6K ﹤0.01% 6490
2024
Q1 		$54.8K Buy
44,200
+32,400
+275% +$38.6K ﹤0.01% 4645
2023
Q4 		$12.4K Sell
11,800
-139,600
-92% -$426K ﹤0.01% 6069
2023
Q3 		$1.04M Buy
151,400
+132,900
+718% +$1.14M ﹤0.01% 2228
2023
Q2 		$192K Sell
18,500
-71,300
-79% -$645K ﹤0.01% 3974
2023
Q1 		$726K Buy
+89,800
New +$1.14M ﹤0.01% 2410
2022
Q3 		– Sell
-1,000
Closed -$14K – 7456
2022
Q2 		$14K Buy
+1,000
New +$14K ﹤0.01% 6543
2022
Q1 		– Sell
-100
Closed -$1K – 7948
2021
Q4 		$1K Sell
100
-1,800
-95% -$27.3K ﹤0.01% 7956
2021
Q3 		$34K Sell
1,900
-25,300
-93% -$406K ﹤0.01% 6825
2021
Q2 		$478K Buy
27,200
+15,300
+129% +$348K ﹤0.01% 4263
2021
Q1 		$300K Buy
11,900
+600
+5% +$11.7K ﹤0.01% 4574
2020
Q4 		$73K Buy
+11,300
New +$47.7K ﹤0.01% 4777
2020
Q1 		– Sell
-600
Closed -$1K – 5171
2019
Q4 		$1K Buy
600
+100
+20% +$166 ﹤0.01% 4955
2019
Q3 		$1K Sell
500
-21,000
-98% -$29.8K ﹤0.01% 4963
2019
Q2 		$47K Buy
+21,500
New +$117K ﹤0.01% 3806

Other funds holding ACRS

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Group One Trading's ACRS Position: Q1 2026 in Review

Group One Trading sold out of Aclaris Therapeutics (ACRS) in Q1 2026, closing a stake of 12,433 shares — an estimated $42K sold.

Group One Trading first reported a position in ACRS in Q1 2019 and held it in 23 quarters. The position peaked at $740K in Q1 2023. 136 funds tracked by Wall St. Rank hold ACRS as of Q1 2026.

  • Group One Trading reported no remaining Aclaris Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 12,433 Aclaris Therapeutics shares in Q1 2026, an estimated $42K.
  • Group One Trading first reported a position in Aclaris Therapeutics in Q1 2019 and held it in 23 quarters.
  • Group One Trading's Aclaris Therapeutics position peaked at $740K in Q1 2023.
  • 136 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.